Cancer Therapy Market, By Therapy Type (Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Thyroid Cancer, Head and Neck Cance
Cancer Therapy Market, By Therapy Type (Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Thyroid Cancer, Head and Neck Cancer, Skin Cancer, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Cancer continues to pose significant healthcare challenges worldwide. Rapidly aging population profiles in numerous countries have contributed to the rising cancer prevalence. Furthermore, increasing environmental pollution levels and lifestyle changes such as unhealthy diets, lack of physical activity, tobacco use, and alcohol consumption have elevated the cancer risk in populations. Despite advancements in therapeutic interventions, cancer mortality remains substantial. As a result, drug development activity in the oncology sector has intensified in recent times focused on improving patient outcomes and quality of life.
Market Dynamics:
The cancer therapy market is driven by various factors such as the increasing prevalence of cancer worldwide owing to changing lifestyle patterns, growing geriatric population, increasing adoption of targeted therapies and personalized medicine, expansion of healthcare infrastructure across emerging nations, and rising investment in cancer R&D by pharmaceutical companies. However, high treatment costs associated with cancer care pose limitations to widespread adoption. Moreover, long regulatory approval timelines for new drug approvals also challenge market growth to some extent. Meanwhile, robust cancer clinical trial pipelines and the entry of biosimilars provide significant opportunities for market expansion over the forecast period.
Key Features of the Study:
This report provides an in-depth analysis of the global cancer therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cancer therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Bayer AG, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., ADC Therapeutics SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eureka Therapeutics, Inc., AbbVie Inc., Fate Therapeutics, Sorrento Therapeutics, Inc., Carrick Therapeutics Limited, Atara Biotherapeutics, Inc., Celluris, NeoTX, and Kazia Therapeutics Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.
Detailed Segmentation-
Therapy Type:
Chemotherapy
Alkylating agents
Antimetabolites
Anti-tumor antibiotics
Others
Target Therapy
Monoclonal antibodies
Small molecule inhibitors
Others
Immunotherapy
Immune Checkpoint Inhibitors
Oncolytic virus therapy
T-cell therapy
Radiotherapy
Others
Cancer Type:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Blood Cancer
Liver Cancer
Thyroid Cancer
Head and Neck Cancer
Skin Cancer
Others
Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
AstraZeneca
Pfizer Inc.
Novartis AG
GSK plc.
Sanofi
Bayer AG
Amgen Inc.
Gilead Sciences, Inc.
Boehringer Ingelheim International GmbH.
ADC Therapeutics SA
Hoffmann-La Roche Ltd
Merck & Co., Inc.
Eureka Therapeutics, Inc.
AbbVie Inc.
Fate Therapeutics
Sorrento Therapeutics, Inc.
Carrick Therapeutics Limited
Atara Biotherapeutics, Inc.
Celluris
NeoTX
Kazia Therapeutics Limited
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Therapy Type
Market Snapshot, By Route of Administration
Market Snapshot, By Cancer Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis
4. Global Cancer Immunotherapy Market- Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the market
5. Global Cancer Immunotherapy Market, By Therapy Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Immune checkpoint inhibitors
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Preventive Vaccines
Therapeutic Vaccines
Adoptive Cell Therapies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Tumor-infiltrating lymphocyte (TIL) therapy
CAR T-cell therapy
Engineered T-cell receptor (TCR) therapy
Natural killer (NK) cell therapy
Immune System Modulators
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Interferons
Immunomodulators (IMiDs)
Interleukins
Monoclonal antibodies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Naked monoclonal antibodies
Conjugated monoclonal antibodies
Bispecific monoclonal antibodies
Oncolytic Virus Therapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Cancer Immunotherapy Market, By Route of Administration, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Subcutaneous
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Intramuscular
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Intravenous (IV)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Cancer Immunotherapy Market, By Cancer Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Lymphoma
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Breast Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Colorectal Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Bladder Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Skin Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Lung Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Kidney Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Cancer Immunotherapy Market, By Distribution Channel, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
9. Global Cancer Immunotherapy Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Gilead Sciences, Inc.
Johnson & Johnson
Actym Therapeutics, Inc.
Bristol-Myers Squibb Company
Pfizer Inc
Novartis AG
Merck & Co., Inc.
Fate Therapeutics
AstraZeneca
Amgen Inc.
GSK plc.
Acumen Pharmaceuticals, Inc
Arcus Biosciences, Inc.
BioNTech SE
Cellectis
immunitybio inc
Autolus Therapeutics
ADC Therapeutics SA.
Gritstone bio
Incyte
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 44 market data tables and 49 figures on Cancer Immunotherapy Market” -Global forecast to 2031